Early treatment intensification with escalated BEACOPP in patients with Hodgkins lymphoma not responding to ABVD therapy

Acta Oncol. 2014 Feb;53(2):286-8. doi: 10.3109/0284186X.2013.862344. Epub 2013 Dec 5.
No abstract available

Publication types

  • Letter
  • Observational Study

MeSH terms

  • Adult
  • Antineoplastic Combined Chemotherapy Protocols / administration & dosage*
  • Bleomycin / administration & dosage
  • Cyclophosphamide
  • Doxorubicin / administration & dosage
  • Etoposide / administration & dosage
  • Female
  • Hodgkin Disease / drug therapy*
  • Hodgkin Disease / mortality
  • Hodgkin Disease / pathology*
  • Humans
  • Kaplan-Meier Estimate
  • Male
  • Middle Aged
  • Neoplasm Recurrence, Local / drug therapy*
  • Neoplasm Recurrence, Local / mortality
  • Neoplasm Recurrence, Local / pathology
  • Prednisone / administration & dosage
  • Procarbazine / administration & dosage
  • Vincristine / administration & dosage
  • Young Adult

Substances

  • Bleomycin
  • Procarbazine
  • Vincristine
  • Etoposide
  • Doxorubicin
  • Cyclophosphamide
  • Prednisone